JPRN-UMIN000033269
Recruiting
未知
Exploratory research of liquid biopsy for patients with cancer - Liquid biopsy for cancer
Cancer Precision Medicine Center Cancer Institute,0 sites800 target enrollmentJuly 4, 2018
Conditionscancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- cancer
- Sponsor
- Cancer Precision Medicine Center Cancer Institute,
- Enrollment
- 800
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who do not satisfy the inclusion criteria
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Investigation on the usefulness of liquid biopsy for tumor-derived circulating DNA in patients with EGFR-mutant NSCLC during and after treatment with EGFR-TKIson-small cell Lung CancerJPRN-UMIN000023248PHRF122
Active, not recruiting
Phase 1
tility of analysis in blood of the evolution of the drug brigatinib for patients with lung cancer with ALK mutationsALK+ non-small cell lung cancerMedDRA version: 20.0Level: LLTClassification code: 10025055Term: Lung cancer non-small cell stage IV Class: 10029104Therapeutic area: Diseases [C] - Neoplasms [C04]CTIS2024-511317-38-00Fundacion GECP33
Active, not recruiting
Phase 1
tility of analysis in blood of the evolution of the drug brigatinib for patients with lung cancer with ALK mutationsALK+ non-small cell lung cancerMedDRA version: 20.0Level: LLTClassification code 10025055Term: Lung cancer non-small cell stage IVSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2019-002369-36-ESFundación GECP30
Not yet recruiting
Not Applicable
Exploratory analysis of liquid biopsy for the predictive factors associated with outcome of PD-1 Pathway Blockade in Multicenter Studynon-small cell lung cancerJPRN-jRCT1032220559Ohe Yuichiro100
Recruiting
Not Applicable
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial CancersEndometrial Clear Cell AdenocarcinomaEndometrial Dedifferentiated CarcinomaEndometrial Mucinous AdenocarcinomaEndometrial Serous AdenocarcinomaMalignant Uterine NeoplasmUterine Corpus CarcinosarcomaNCT05049538M.D. Anderson Cancer Center1,000